SSRIs effectively treat premenstrual symptoms.
Selective serotonin reuptake inhibitors (SSRIs) (i.e., citalopram, fluoxetine, paroxetine, and sertraline) effectively treat premenstrual symptoms, particularly with continuous dosing, but perhaps not as effectively as previously reported, according to the findings of a recent meta-analysis.
Researchers included 29 published double-blind, randomized controlled studies involving almost 3,000 women in their analysis.
Overall, they found SSRIs significantly effective for treating both PMS and premenstrual dysphoric disorder (OR, 0.40; 95% CI, 0.31–0.51). While no particular SSRI was more effective than another, continuous dosing regimens were more effective (OR, 0.28; 95% CI, 0.18–0.42) than intermittent ones (OR, 0.55; 95% CI, 0.45–0.68).
Shah NR, Jones JB, Aperi J, et al. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstet Gynecol. 2008;111:1175-1182.
A Legacy of Excellence: Reflecting on the Final Print Edition of Contemporary OB/GYN
April 25th 2025Marking the end of an era and the beginning of a new chapter, the final print edition of Contemporary OB/GYN celebrates over 50 years of evidence-based guidance and unwavering support for clinicians.
Read More